Serum levels of preS antigen (HBpreSAg) in chronic hepatitis B virus infected patients
2007

Detecting PreS Antigen in Chronic Hepatitis B Patients

Sample size: 154 publication 10 minutes Evidence: moderate

Author Information

Author(s): Lian Min, Zhou Xu, Wei Lai, Qiu Shihong, Zhou Tong, Li Lanfen, Gu Xiaocheng, Luo Ming, Zheng Xiaofeng

Primary Institution: Peking University

Hypothesis

Can preS antigen levels serve as a reliable indicator for managing chronic hepatitis B virus infection?

Conclusion

The study found that HBpreSAg levels correlate well with HBsAg and HBV DNA copies, suggesting it could be a valuable marker for predicting treatment outcomes.

Supporting Evidence

  • 70% of HBeAg-positive patients showed HBpreSAg positive.
  • 30 out of 47 HBpreSAg positive patients showed no evidence of viral replication.
  • The overall accuracy of the HBpreSAg test could reach 72% for active HBV replication.

Takeaway

This study shows that a special test can find a marker in the blood of people with hepatitis B, which helps doctors know how well the treatment is working.

Methodology

A double antibody sandwich ELISA was used to measure serum HBpreSAg levels in chronic hepatitis B patients.

Potential Biases

Potential bias due to high levels of HBsAg interfering with HBpreSAg measurements.

Limitations

The study was limited by the number of patients, which restricted reliable statistical analysis among different response types.

Participant Demographics

Patients included 104 HBeAg-negative and 50 HBeAg-positive chronic hepatitis B patients.

Statistical Information

P-Value

0.01

Confidence Interval

95% CI, 55–78

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1743-422X-4-93

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication